Skip to main content
Equibles
OPCH logo

OPCH · Option Care Health, Inc. · Metrics

Track OPCH — free

Use OPCH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OPCH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$31.22 -0.07 (-0.22%) At close · Oct 23
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.90B
Shares
157.03M
Volume · Oct 23 2.65M Avg daily vol (3M) 3.83M

OPCH metrics

106 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$31.22
Market cap
$4.90B

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
+35.3%
Price change (3M)
+44.1%
Price change (6M)
+9.9%
Price change (YTD)
-2.0%
Price change (1Y)
+11.3%
Trailing year
Price change (5Y)
+18.1%
52-week high
$36.59
52-week low
$19.52
Change from 52-week high
-14.7%
Change from 52-week low
+59.9%
Annualized volatility
52.8%
Annualized volatility (3M)
69.8%
Beta
0.1
RSI (14D)
82.0
Price vs SMA 50
+21.4%
Price vs SMA 200
+18.4%
Avg volume (3M)
3.83M
Relative volume
0.7
Average dollar volume
$105.69M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
157.03M

Valuation

12 metrics
P / E (TTM)
23.7
Trailing earnings · reciprocal yield 4.2%
PEG ratio
1.8
EV / revenue
1.0×
reciprocal yield 97.0%
EV / EBITDA
14.6×
reciprocal yield 6.8%
EV / EBIT
17.6×
reciprocal yield 5.7%
P / sales
0.9×
reciprocal yield 116.1%
P / book
3.9
reciprocal yield 25.7%
FCF yield
6.2%
TTM · current market cap
Buyback yield
6.7%
P / FCF
16.1
reciprocal yield 6.2%
P / operating cash flow
14.1
reciprocal yield 7.1%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
21.9×
reciprocal yield 4.6%
P / E historical average (5Y)
25.4×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
1.1×
reciprocal yield 88.6%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 74.0%
EV / EBIT historical average (3Y)
17.2×
reciprocal yield 5.8%
EV / EBIT historical average (5Y)
21.9×
reciprocal yield 4.6%
EV / EBITDA historical average (3Y)
14.4×
reciprocal yield 6.9%
EV / EBITDA historical average (5Y)
17.6×
reciprocal yield 5.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
19.1%
Operating margin
5.9%
Trailing 12 months
Net margin
3.7%
Gross profit (TTM)
$1.09B
Operating profit (TTM)
$333.69M
Net income (TTM)
$209.58M
Trailing 12 months
Diluted EPS (TTM)
$1.32
FCF margin
5.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$35.92
Gross profit per diluted share (TTM)
$6.84
Operating profit per diluted share (TTM)
$2.11
EBITDA per diluted share (TTM)
$2.53
Net income per diluted share (TTM)
$1.32
Operating cash flow per diluted share (TTM)
$2.20
Free cash flow per diluted share (TTM)
$1.93
Capital expenditures per diluted share (TTM)
$0.27
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.25
Book value per share
$8.41

Growth

11 metrics
Revenue growth YoY
+1.9%
Year over year
Net income growth YoY
+6.7%
Revenue (TTM)
$5.69B
Trailing 12 months
EPS growth YoY
+12.9%
Shares change YoY
-6.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.7%
Revenue CAGR (5Y)
+13.3%
EPS CAGR (3Y)
+15.2%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-2.2%
FCF CAGR (5Y)
+16.7%

Quality

14 metrics
Return on equity
16.6%
Return on assets
6.2%
Debt / equity
0.9
Current ratio
1.5
EBITDA (TTM)
$401.60M
Free cash flow (TTM)
$303.85M
Quick ratio
1.0
Interest coverage
6.2
Net debt / EBITDA
2.4
Return on invested capital
—
Trailing 12 months
Net cash
−$965.05M
Latest balance sheet
Cash & equivalents
$193.77M
Total assets
$3.38B
Total debt
$1.16B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$346.81M
Capital expenditures (TTM)
$42.96M
R&D (TTM)
—
SG&A (TTM)
$683.46M
Stock compensation (TTM)
$39.02M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
375
13F filer change QoQ
-3
Institutional ownership
101.2%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
21.9%
Private-fund adviser ownership
21.2%
Active holders' share change QoQ
-10.8%
Holder tenure
13.0
Price vs estimated holder cost
-26.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.6%

Short interest

3 metrics
Short interest
5.5%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1014739 CUSIP 68404L201 13F (30d) 62 filings 61 filers Visit website Investor relations